NCT01480440Active, not recruiting
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Prospective Post Market Clinical Follow-up Study of the Zimmer Trabecular Metal Reverse Should System Used in Primary or Revision Reverse Total Shoulder Arthroplasty
Source: ClinicalTrials.gov · Last updated 28 Apr 2026
Brief summary (registry, in English)
The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 23 Nov 2011
- Start date
- Jan 2011
- Primary completion date
- Dec 2026
- Lead sponsor
- Zimmer Biomet
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT01480440
What you commit to
- Study type: Observational
- Planned participants: 200
- From Jan 2011 to the primary completion date, Dec 2026
- 5 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The patient is a known alcohol or drug abuser;
Other illness
- The patient has one of the following compromising the affected limb: a significant injury to the upper brachial plexus, paralysis of the axillary nerve or a neuromuscular disease compromising the affected limb which would render the procedure unjustifiable;
- The patient has a local/systemic infection;
- The patient has a known sensitivity or allergic reaction to one or more of the implanted materials;
Other
- The patient is a prisoner;
- The patient is mentally incompetent or unable to understand what participation in the study entails;
- The patient is anticipated to be non-compliant;
- The patient is known to be pregnant;
- The patient has marked bone loss;
- The patient is unwilling or unable to give consent or to comply with the follow-up program.
Who the study is looking for
- Patient is \> 18 years of age;
- Patient is skeletally mature;
- Patient qualifies for primary or revision unilateral or bilateral reverse total shoulder arthroplasty based on physical exam and medical history including the following: osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, ununited humeral head fracture, irreducible 3-and 4-part proximal humeral fractures, avascular necrosis, gross rotator cuff deficiency or failed total shoulder arthroplasty (both glenoid and humeral components require revision);
- Patient is willing and able to provide written informed consent;
- Patient is willing and able to cooperate in the required post-operative therapy;
- Patient is willing and able to complete scheduled follow-up evaluations/questionnaires as described in the Informed Consent;
- Patient has participated in the Informed Consent process and has signed the Institutional Review Board (IRB)/Ethical Review Board (ERB) approved informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Royal Blackburn Hospital Coordinator of this site? Confirm its status | Blackburn | United Kingdom | Unknown status |
| The Rothman Institute Coordinator of this site? Confirm its status | Egg Harbor | United States | Unknown status |
| Norton Orthopaedic & Sports Medicine Coordinator of this site? Confirm its status | Louisville | United States | Unknown status |
| The Rothman Institute Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.